Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    Open Studies | "Leishmaniasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leishmaniasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
Condition: Leishmaniasis
Interventions: Drug: Meglumine antimoniate;   Drug: Miltefosine;   Drug: Pentoxifylline
2 Not yet recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
3 Not yet recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
4 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
5 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
6 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
Condition: Leishmaniasis or Other Uses of Miltefosine
Intervention: Drug: Miltefosine
7 Not yet recruiting Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Topical Amphotericin-B 0.4% liposomal gel
8 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
9 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
10 Not yet recruiting Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Pentostam
11 Not yet recruiting Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
12 Recruiting Asymptomatic Leishmania Infection in HIV Patients
Condition: Visceral Leishmaniasis
Intervention:
13 Recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
14 Not yet recruiting Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
Conditions: Cutaneous Leishmaniasis;   Skin Diseases, Parasitic;   Neglected Diseases
Intervention:
15 Recruiting Diagnosis and Treatment of Leishmanial Infections
Condition: Leishmaniasis
Intervention:
16 Not yet recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH

Study has passed its completion date and status has not been verified in more than two years.